Bucladesine Attenuates Spatial Learning and Hippocampal Mitochondrial Impairments Induced by 3, 4-Methylenedioxymethamphetamine (MDMA)

• Published in: Neurotoxicity research 2020-06, Vol.38 (1), p.38-49
• Main Authors: Taghizadeh, Ghorban, Mehdizadeh, Hajar, Pourahmad, Jalal, Foroumadi, Alireza, Hassani, Shokoufeh, Halvaei Khankahdani, Zahra, Noruzi, Marzieh, Behmadi, Homayoon, Lavasani, Hoda, Rouini, Mohammad Reza, Sharifzadeh, Mohammad
• Format: Article
• Language: English
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Bucladesine - administration & dosage; Cell Biology; Hippocampus - drug effects; Hippocampus - metabolism; Male; Mitochondria - drug effects; Mitochondria - metabolism; N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage; Neurobiology; Neurochemistry; Neurology; Neurosciences; Original Article; Pharmacology/Toxicology; Rats, Wistar; Reactive Oxygen Species - metabolism; Spatial Learning - drug effects; Spatial Memory - drug effects
• ISSN: 1029-8428; 1476-3524
• DOI: 10.1007/s12640-020-00183-3

Neurotoxic effects of systemic administration of 3, 4- methylenedioxymethamphetamine (MDMA) has been attributed to MDMA and its metabolites. However, the role of the parent compound in MDMA-induced mitochondrial and memory impairment has not yet been investigated. Moreover, it is not yet studied that analogs of 3′, 5′-cyclic adenosine monophosphate (cAMP) could decrease these neurotoxic effects of MDMA. We wished to investigate the effects of the central administration of MDMA on spatial memory and mitochondrial function as well as the effects of bucladesine, a membrane-permeable analog of cAMP, on these effects of MDMA. We assessed the effects of pre-training bilateral intrahippocampal infusion of MDMA (0.01, 0.1, 0.5, and 1 μg/side), bucladesine (10 and 100 μM) or combination of them on spatial memory, and different parameters of hippocampal mitochondrial function including the level of reactive oxygen species (ROS) production, mitochondrial membrane potential (MMP), mitochondrial swelling, mitochondrial outer membrane damage, the amount of cytochrome c release as well as hippocampal ADP/ATP ratio. The results showed that MDMA caused spatial memory impairments as well as mitochondrial dysfunction as evidenced by the marked increase in hippocampal ADP/ATP ratio, ROS level, the collapse of MMP, mitochondrial swelling, and mitochondrial outer membrane damage leading to cytochrome c release from the mitochondria. The current study also found that bucladesine markedly reduced the destructive effects of MDMA. These results provide evidence of the role of the parent compound (MDMA) in MDMA-induced memory impairments through mitochondrial dysfunction. This study highlights the role of cAMP/PKA signaling in MDMA-induced memory and mitochondrial defects.